What is the latest research on Hodgkins disease?
Children’s Hospital and Dana-Farber Cancer Institute are part of a national consortium of clinical trials that focus on decreasing the long-term effects of Hodgkin’s disease and its treatments, and, ultimately, increasing cure rates for childhood Hodgkin’s disease. The Dana-Farber/Children Hospital program is also part of the Children’s Oncology Group, a national group of pediatric oncologists whose work includes investigational drug therapy for patients with Hodgkin’s disease who experience relapse. In the area of stem cell transplantation, the Dana-Farber/Children’s Transplant Program is one of only eight institutions around the country that is investigating the use of umbilical cord transplantation. Also under study is a novel method for preventing graft versus host disease, a serious complication that occurs when transplanted cells do not recognize the tissues and organs of the recipient’s body and react against the recipient’s tissue. The result of this treatment approach, if it c
